English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Cite this article as: Yıldırım Köpük Ş, Çakıroğlu Y, Ceylan Y, Çekmen MB, Yücesoy G. Prediction of Preeclampsia by Uterine Artery Doppler Examination and Placental Growth Factor, Endoglin and Pregnancy-associated Plasma Protein Levels in Maternal Serum at 11-13+6 Pregnancy Week. Eur Arch Med Res 2019;35(3):137-42 Received: 10.12.2017 Accepted: 03.09.2018 Address for Correspondence: Şule Yıldırım Köpük, Ümraniye Training and Research Hospital, Clinic of Obstetrics and Gynecology, İstanbul, Turkey Phone: +90 505 474 11 32 E-mail: suleyildirim@msn.com ORCID ID: orcid.org/0000-0002-5020-8323 Objective: We aimed to evaluate the prediction of preeclampsia by maternal serum pregnancy-associated plasma protein A (PAPP-A), placental growth factor (PIGF), sEndoglin (sEng) and uterine artery Doppler examination. Methods: One hundred and ninety-three singleton pregnant women admitted to outpatient clinic at 11-13+6 weeks for first trimester combined screening test were included in the study. Maternal history was taken, and uterine artery Doppler examination and serum biomarker screening (PAPP-A, PIGF, sEndoglin) were conducted. The follow-up results of pregnancy were recorded. The study cohort was divided into two groups as “control” and “preeclampsia”. Mann-Whitney U and chi-square tests were used for comparison of independent variables. Sensitivity and specificity for the predictive values of the significant parameters were calculated from ROC curves. Results: Of 193 women, 168 women (87%) were in the control group (group 1) and 25 women (12.9%) who developed preeclampsia were defined in the preeclampsia group. In preeclampsia group, 20 women (10.3%) with gestational hypertension and mild preeclampsia were defined as “group 2”, and five women (2.5%) with severe preeclampsia and hemolysis, elevated liver enzymes, low platelet were defined as “group 3”. Maternal serum PAPP-A, PIGF, sEng levels were not significantly different between preeclampsia group and control group, whereas uterine artery Doppler pulsatility index (PI) values were significantly higher in preeclampsia group (p=0.023). sEng levels were significantly higher in group 3 than those in group 2 (p=0.001). If uterine artery PI cut-off level was taken as >2.23 in ROC curve analysis, sensitivity was 42.31% and specificity was 82.10% for detecting preeclampsia. Conclusion: Maternal serum PAPP-A, PIGF and sEng were not effective in predicting preeclampsia. However, these markers can be used to distinguish between mild and severe preeclampsia. First trimester uterine artery Doppler examination is an effective screening method for predicting preeclampsia.

european archives of medical research

Prediction of Preeclampsia by Uterine Artery Doppler Examination and Placental Growth Factor, Endoglin and Pregnancy-associated Plasma Protein Levels in Maternal Serum at 11-13+6 Pregnancy Week